Detection of Clinically Relevant Copy Number Variants with Whole‐Exome Sequencing

Copy number variation (CNV) is a common source of genetic variation that has been implicated in many genomic disorders. This has resulted in the widespread application of genomic microarrays as a first‐tier diagnostic tool for CNV detection. More recently, whole‐exome sequencing (WES) has been proven successful for the detection of clinically relevant point mutations and small insertion–deletions exome wide. We evaluate the utility of short‐read WES (SOLiD 5500xl) to detect clinically relevant CNVs in DNA from 10 patients with intellectual disability and compare these results to data from two independent high‐resolution microarrays. Eleven of the 12 clinically relevant CNVs were detected via read‐depth analysis of WES data; a heterozygous single‐exon deletion remained undetected by all algorithms evaluated. Although the detection power of WES for small CNVs currently does not match that of high‐resolution microarray platforms, we show that the majority (88%) of rare coding CNVs containing three or more exons are successfully identified by WES. These results show that the CNV detection resolution of WES is comparable to that of medium‐resolution genomic microarrays commonly used as clinical assays. The combined detection of point mutations, indels, and CNVs makes WES a very attractive first‐tier diagnostic test for genetically heterogeneous disorders.

[1]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[2]  P. Stankiewicz,et al.  Incidental copy-number variants identified by routine genome testing in a clinical population , 2012, Genetics in Medicine.

[3]  S. Hochreiter,et al.  cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate , 2012, Nucleic acids research.

[4]  Agus Salim,et al.  Statistical challenges associated with detecting copy number variations with next-generation sequencing , 2012, Bioinform..

[5]  Bradley P. Coe,et al.  Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.

[6]  P. Stankiewicz,et al.  Detection of clinically relevant exonic copy‐number changes by array CGH , 2010, Human mutation.

[7]  Jason Li,et al.  CONTRA: copy number analysis for targeted resequencing , 2012, Bioinform..

[8]  Philip M. Kim,et al.  The current excitement about copy-number variation: how it relates to gene duplications and protein families. , 2008, Current opinion in structural biology.

[9]  Timothy B. Stockwell,et al.  The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.

[10]  Gregory M. Cooper,et al.  A Copy Number Variation Morbidity Map of Developmental Delay , 2011, Nature Genetics.

[11]  Ryan Mills,et al.  Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants , 2011, Nature Biotechnology.

[12]  Heather C Mefford,et al.  Duplication hotspots, rare genomic disorders, and common disease. , 2009, Current opinion in genetics & development.

[13]  Michael Egmont-Petersen,et al.  Genome-wide Copy Number Profiling on High-density Bacterial Artificial Chromosomes, Single-nucleotide Polymorphisms, and Oligonucleotide Microarrays: A Platform Comparison based on Statistical Power Analysis , 2007, DNA research : an international journal for rapid publication of reports on genes and genomes.

[14]  J. Lupski Brain Copy Number Variants and Neuropsychiatric Traits , 2012, Biological Psychiatry.

[15]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[16]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[17]  Pawel Stankiewicz,et al.  Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. , 2007, Current opinion in genetics & development.

[18]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[19]  Ton Feuth,et al.  Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. , 2003, American journal of human genetics.

[20]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[21]  Kenny Q. Ye,et al.  Mapping copy number variation by population scale genome sequencing , 2010, Nature.

[22]  J. Lupski,et al.  Human genome sequencing in health and disease. , 2012, Annual review of medicine.

[23]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[24]  David R. Murdock,et al.  Exploring the utility of whole‐exome sequencing as a diagnostic tool in a child with atypical episodic muscle weakness , 2013, Clinical genetics.

[25]  J. Lupski,et al.  The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans , 2009, Nature Genetics.

[26]  Yu-ping Wang,et al.  Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies , 2013, PloS one.

[27]  M. Metzker Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[28]  Nicholas W. Wood,et al.  A robust model for read count data in exome sequencing experiments and implications for copy number variant calling , 2012, Bioinform..

[29]  Christian Gilissen,et al.  Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.

[30]  J. Wiszniewska,et al.  Copy number and SNP arrays in clinical diagnostics. , 2011, Annual review of genomics and human genetics.

[31]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[32]  P. Stankiewicz,et al.  Structural variation in the human genome and its role in disease. , 2010, Annual review of medicine.

[33]  J. Lupski,et al.  Genomic disorders ten years on , 2009, Genome Medicine.

[34]  L. Vissers,et al.  Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis , 2009, Journal of Medical Genetics.

[35]  E. Banks,et al.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. , 2012, American journal of human genetics.

[36]  J. Lupski,et al.  Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency , 2005, Genetics in Medicine.

[37]  M. Shaw,et al.  Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. , 2010, American journal of human genetics.

[38]  Mark Gerstein,et al.  Genome-Wide Mapping of Copy Number Variation in Humans: Comparative Analysis of High Resolution Array Platforms , 2011, PloS one.

[39]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[40]  J. Lupski,et al.  De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome , 2013, Genome Medicine.

[41]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[42]  Eric P Hoffman,et al.  Genomics , Intellectual Disability , and Autism , 2012 .

[43]  Guillén Fernández,et al.  Genetic Variation in CACNA1C, a Gene Associated with Bipolar Disorder, Influences Brainstem Rather than Gray Matter Volume in Healthy Individuals , 2010, Biological Psychiatry.

[44]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.